Clinical Trial Update: A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma [Phase 1]

View source ↗

Summary

Phase 1 trial update for a drug interaction study of tasisulam in patients with advanced cancer or lymphoma; study terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lymphoma

Drugs mentioned

• Tasisulam (tasisulam)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Lymphoma, Advanced Cancer | Phase 1 | Status: TERMINATED | Results posted: 2018-10-19